|
|
Barbara |
|
Holtz PhD |
|
Life Sciences Value Expert |
BIOVIA, Dassault Systèmes |
https://proventainternational.com/wp-content/uploads/2022/05/Barbara-Holtz.jpg |
Barbara has over 20 years of experience working in the Life Sciences, mostly in customer facing roles. She has been working for a range of IT and Software companies, most recently as a Value Expert at Dassault Systemes, helping to improve the way scientists and engineers in the Life Science Industry work with digital, data, modeling and simulation. She has a background in Physics, having completed in PhD in Molecular Simulations and is currently focusing to apply her analytical skills and deep industry knowledge to understand virtual twins and the benefits they can deliver across the entire pharma, medical device and biotech value chain. |
|
|
Dr. |
|
Björn Loeprecht |
|
Industry Process Consultant BIOVIA |
Dassault Systèmes |
https://proventainternational.com/wp-content/uploads/2022/05/Bjoern-Loeprecht.jpg |
Dr. Björn Loeprecht is an Industry Process Consultant at BIOVIA, Dassault Systèmes. He has helped building strategic relationships with a number of key Dassault Systèmes partners, by designing scientific innovation and information strategies. He has consulted many chemical and life science companies in streamlining and digitalizing their R&D processes. Dr. Loeprecht holds a Ph.D. in Theoretical Chemistry from Leipzig University. |
|
|
Cyril |
|
Walsh |
|
Solutions Sales Specialist |
BIOVIA |
https://proventainternational.com/wp-content/uploads/2022/05/Cyril-Walsh.jpg |
Cyril has 18 years’ experience in the Life Sciences sector supporting Tier 1 client organisations in their strategic decisions to software acquisitions, implementations and support. With a focus on quality management and laboratory execution Cyril is currently fulfilling the role of Solutions Sales Specialist for BIOVIA, the organisation which provides global, collaborative product lifecycle experiences to transform scientific innovation. |
|
|
Mike |
|
Shrimpton |
|
Sales Manager UK & Ireland |
Quantum |
https://proventainternational.com/wp-content/uploads/2022/01/Mike-Shrimpton.jpg |
Mike brings over 35 years of experience in the storage industry, with roles in a number of OEM’s, including Oracle and Quantum. Much of his career has held a strong emphasis on data storage, management and protection. Mike is currently working with research and pharmaceutical organisations, and at the Bioinformatics Strategy Meetings showcasing Quantum’s leading capability to manage and protect petabyte-scale data challenges and beyond. |
|
|
Sean |
|
McDonnell |
|
Scientific Solutions Consultant |
Benchling |
https://proventainternational.com/wp-content/uploads/2022/06/sean-mcdonell.jpg |
|
|
|
Tali |
|
Weinberg Bloom |
|
Enterprise Software Sales Leader/Revenue Growth Generator |
Benchling |
https://proventainternational.com/wp-content/uploads/2022/05/Tali-Weinberg-Bloom.jpg |
|
|
|
Dannys |
|
Martinez |
|
FAS Bioinformatics EMEA |
PerkinElmer Informatics |
https://proventainternational.com/wp-content/uploads/2022/05/Martinez-Dannys-1.jpg |
|
|
|
Christian |
|
Baber |
|
Head of Scientific & Pharmaceutical Data, Informatics & Systems |
The Janssen Pharmaceutical Companies of Johnson & Johnson |
https://proventainternational.com/wp-content/uploads/2020/08/christian-baber.jpeg |
Christian Baber, is a chemist by training and holds undergraduate and PhD degrees in computational chemistry with a focus on AI techniques to assess the synthetic accessibility of de novo design compounds. Christian continued this work with a post-doctoral fellowship on the automated design of targeted combinatorial libraries at the Department of Knowledge Engineering, Osaka University, Japan before moving into industry initially as a computational chemist and cheminformatician. Christian has a wide breadth of experience across companies ranging from startups to Pfizer and diverse therapeutic areas with a focus on informatics and predictive modeling but has also managed lab groups and automation teams including compound management and high-throughput purification. Christian joined Shire in 2015 leading Scientific Computing & Informatics before moving on to lead R&D IT in 2017. Christian remained with Takeda following its acquisition of Shire 2019 and is currently the Global Head of Scientific Informatics, covering technology and decision support across all of the scientific R&D functions from research to non-clinical development and pharmaceutical sciences. |
|
|
Philip |
|
Beer |
|
VP, Head of Research and Translational Medicine |
Step Pharma |
https://proventainternational.com/wp-content/uploads/2020/01/Philip-Beer_DEC2021.jpg |
Dr Philip Beer is a physician scientist and precision oncology specialist who holds diverse roles across the healthcare, academic and commercial sectors. Philip has hands-on experience in the design and execution of translational medicine programmes, drawing on state-of-the-art processes and analytics to inform mechanism of action and identify novel markers of response and resistance. This work is underpinned by an active portfolio of basic research focused on cancer biology and genomics, through honorary positions at the Sanger Institute, UK, and Mayo Clinic, USA.
|
|
|
David |
|
Cook |
|
Chief Scientific Officer |
Blueberry Therapeutics |
https://proventainternational.com/wp-content/uploads/2021/05/David-Cook-Picture-scaled-e1620994581914.jpeg |
David has a background in biochemistry, immunology and molecular biology with a PhD from Imperial College, London and three years of academic post-doctoral experience. David has worked in the pharmaceutical industry for over 20 years. He worked in big pharma at AstraZeneca for more than 17 years in a wide variety of R&D roles both in the UK and the US. Whilst at AstraZeneca he worked on numerous drug projects from target selection through to supporting market products. He was also heavily involved in an in-depth analysis of AZ’s drug portfolio and understanding why projects fail and was the lead author on AZ’s “5Rs Paper” describing the learnings from this exercise. David joined Blueberry Therapeutics as Chief Scientific Officer at the start of 2014. In this role, he is responsible for leading the research activities of the business which are focused on developing new treatments for common dermatological diseases. |
|
|
James |
|
Hooley |
|
VP, Head of Enterprise Data Platforms & Products |
Takeda |
https://proventainternational.com/wp-content/uploads/2020/01/James-Hooley-scaled-e1641469830620.jpg |
James is the Global Head of Enterprise Data Platforms and Products for Takeda – a team focused on enabling the Data & Digital Takeda strategy with ‘platform and data solutions’ as products and services.
Takeda’s journey expands and advances the translation of science into highly innovative medicines while maintaining agility as a global, values-based, R&D-driven, biopharmaceutical leader.
James advocates a ‘people first’ approach that has continuously enabled successful and motivated teams to deliver strategic and measurable business value. With a hands-on business and technical foundation, James is able to drive trusted and authentic partnerships across all Data Management dimensions, leading to an improved end-user experience and accelerated returns on investment.
Since starting his career in 1997 as a graduate recruit in IT consultancy, James has continuously advanced through various data-related roles, technology platforms and geographies. It was in 2012 that James joined Baxter Healthcare in Switzerland as the IT Business Relationship Manager for ECEMEA, Russia and CIS – transitioning to pharmaceuticals and becoming involved in projects stretching across multiple disease states and disciplines. James transitioned through M&A to Baxalta in 2015 as the EMEA IT Program Office Director and then with the acquisition of Baxalta into Shire in 2018 became the Head of Commercial IT for the European region. Since 2019 and the subsequent acquisition of Shire by Takeda, James has led a Global Master Data Management program from within the ERP IT organization and is now the Global Head of Enterprise Data Platforms & Products at Takeda. |
|
|
Adam |
|
Sardar |
|
Head of Data Science, Computational Products |
e-therapeutics PLC |
https://proventainternational.com/wp-content/uploads/2022/01/adam-sardar.jpeg |
|
|
|
Nadeem |
|
Sarwar |
|
Global Head, Genomic Strategies & Global Head, Digital Therapeutics (DTx) Strategies |
Eisai EMEA |
https://proventainternational.com/wp-content/uploads/2022/04/Nadeem-Sarwar.jpg |
Nadeem Sarwar’s expertise stems from the intersection of genomics, data sciences and digital technologies with collaborative business models to drive innovative therapeutic solutions. He was recently been appointed as the Global Head, Genomic Strategies and Global Head, Digital Therapeutics (DTx) Strategies at Eisai, having previously served as Founder and President of the 100-scientist Eisai Center for Genetics Guided Dementia Discovery (G2D2). He has executive experience in academia (Cambridge), pharma (Pfizer, Eisai), and Biotech (G2D2); has successfully built and led organizations across the UK, US and Japan; and contributed to delivery of therapeutics into clinical trials for cardiovascular diseases, immunology, oncology, COVID-19 and dementia. |
Radisson Blu Hotel, Stansted Airport
Payment Securely powered by stripe
